Used as a key intermediate in the synthesis of pharmaceutical agents, particularly in the development of kinase inhibitors for targeted cancer therapies. Its chiral oxazole core enables selective interactions with biological targets, enhancing drug potency and reducing off-target effects. Commonly employed in research settings to optimize lead compounds for improved metabolic stability and bioavailability. Also utilized in the preparation of analogs for structure-activity relationship (SAR) studies in drug discovery programs.